Elif Yılmazel Uçar

964 total citations
80 papers, 628 citations indexed

About

Elif Yılmazel Uçar is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Internal Medicine. According to data from OpenAlex, Elif Yılmazel Uçar has authored 80 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 14 papers in Internal Medicine. Recurrent topics in Elif Yılmazel Uçar's work include Venous Thromboembolism Diagnosis and Management (14 papers), Respiratory Support and Mechanisms (10 papers) and COVID-19 Clinical Research Studies (7 papers). Elif Yılmazel Uçar is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (14 papers), Respiratory Support and Mechanisms (10 papers) and COVID-19 Clinical Research Studies (7 papers). Elif Yılmazel Uçar collaborates with scholars based in Türkiye, United States and France. Elif Yılmazel Uçar's co-authors include Metin Akgün, Ömer Araz, Buğra Kerget, Leyla Sağlam, Mehmet Meral, Metin Görgüner, Ferhan Kerget, Adem Karaman, Hasan Kaynar and Fatih Alper and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Journal of Medical Virology.

In The Last Decade

Elif Yılmazel Uçar

71 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elif Yılmazel Uçar Türkiye 14 252 94 92 92 87 80 628
Ali Nihat Annakkaya Türkiye 14 133 0.5× 85 0.9× 82 0.9× 30 0.3× 22 0.3× 48 476
Rosa M. Estrada‐Y‐Martin United States 14 317 1.3× 53 0.6× 213 2.3× 20 0.2× 64 0.7× 52 695
Marc C. Smaldone United States 16 149 0.6× 65 0.7× 89 1.0× 143 1.6× 24 0.3× 55 861
Tatiana Helena Rech Brazil 15 64 0.3× 63 0.7× 117 1.3× 104 1.1× 34 0.4× 42 642
Hayriye Sayarlıoğlu Türkiye 17 205 0.8× 127 1.4× 180 2.0× 33 0.4× 17 0.2× 65 857
Nuri Tutar Türkiye 13 245 1.0× 45 0.5× 95 1.0× 21 0.2× 23 0.3× 66 531
Şevket Özkaya Türkiye 12 259 1.0× 84 0.9× 67 0.7× 16 0.2× 17 0.2× 58 480
Nihal Demirel Türkiye 16 345 1.4× 40 0.4× 149 1.6× 95 1.0× 16 0.2× 91 790
Talal Almas Ireland 14 82 0.3× 170 1.8× 90 1.0× 32 0.3× 21 0.2× 120 678
Christian Urbanek Germany 12 128 0.5× 34 0.4× 342 3.7× 41 0.4× 48 0.6× 25 622

Countries citing papers authored by Elif Yılmazel Uçar

Since Specialization
Citations

This map shows the geographic impact of Elif Yılmazel Uçar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elif Yılmazel Uçar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elif Yılmazel Uçar more than expected).

Fields of papers citing papers by Elif Yılmazel Uçar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elif Yılmazel Uçar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elif Yılmazel Uçar. The network helps show where Elif Yılmazel Uçar may publish in the future.

Co-authorship network of co-authors of Elif Yılmazel Uçar

This figure shows the co-authorship network connecting the top 25 collaborators of Elif Yılmazel Uçar. A scholar is included among the top collaborators of Elif Yılmazel Uçar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elif Yılmazel Uçar. Elif Yılmazel Uçar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Araz, Ömer, Elif Yılmazel Uçar, Fatih Alper, et al.. (2022). Long-term follow-up of young denim sandblasters in Turkey. Occupational Medicine. 72(6). 403–410. 6 indexed citations
4.
Kerget, Buğra, Ferhan Kerget, Abdullah Osman Koçak, et al.. (2021). Is endogenous carboxyhaemoglobin level a useful biomarker of clinical course and prognosis in COVID‐19 patients?. International Journal of Clinical Practice. 75(11). e14680–e14680. 6 indexed citations
5.
Uçar, Elif Yılmazel, Ömer Araz, Buğra Kerget, et al.. (2021). A 19-Year-Old-Woman With Backache, Hemoptysis, and Hypereosinophilia. CHEST Journal. 159(4). e231–e235. 2 indexed citations
6.
Uçar, Elif Yılmazel, et al.. (2020). Can tissue elemental analysis be used to differentiate sarcoidosis and tuberculous lymphadenitis?. Tuberkuloz ve Toraks. 68(2). 126–134. 2 indexed citations
7.
Kerget, Buğra, Ferhan Kerget, Abdullah Osman Koçak, et al.. (2020). Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?. Lung. 198(5). 777–784. 57 indexed citations
8.
Araz, Ömer, Adem Karaman, Elif Yılmazel Uçar, Leyla Sağlam, & Metin Akgün. (2019). Behçet's Disease: Different Systemic Manifestations at Different Ages. Eurasian Journal of Medicine. 52(3). 304–306. 1 indexed citations
9.
Uçar, Elif Yılmazel, et al.. (2018). The effect of surgical specimen-derived phosphorus and lead concentrations in non-small cell lung cancer patients on disease course. Tuberkuloz ve Toraks. 66(4). 334–339. 2 indexed citations
10.
Araz, Ömer, et al.. (2018). The effect of unilateral forced nostril breathing on sleep in healthy right-handed men: a preliminary report. Sleep And Breathing. 22(3). 769–772. 3 indexed citations
11.
Araz, Ömer, et al.. (2017). Predictive Value of Mean Platelet Volume for Pulmonary Embolism Recurrence. Lung. 195(4). 497–502. 12 indexed citations
12.
Uğurlu, Aylin Özsancak, Huriye Berk Takır, Begüm Ergan, et al.. (2016). Approach of pulmonologists in Turkey to noninvasive mechanical ventilation use at home for chronic respiratory failure. Tuberkuloz ve Toraks. 64(1). 1–8. 2 indexed citations
13.
Uçar, Elif Yılmazel, Ömer Araz, Nafiye Yılmaz, et al.. (2014). Effectiveness of pharmacologic therapies on smoking cessation success: Results of three years of smoking cessation clinic. European Respiratory Journal. 44(Suppl 58). P4453–P4453. 1 indexed citations
14.
Araz, Ömer, Elif Yılmazel Uçar, Mehmet Meral, et al.. (2014). Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5‐year survival. The Clinical Respiratory Journal. 9(3). 297–304. 13 indexed citations
15.
Araz, Ömer, Elif Demirci, Elif Yılmazel Uçar, et al.. (2014). The roles of Ki-67, p53, transforming growth factor- and lysyl oxidase in the metastasis of lung cancer. European Respiratory Journal. 44(Suppl 58). P345–P345. 1 indexed citations
16.
Uçar, Elif Yılmazel, Ömer Araz, Nafiye Yılmaz, et al.. (2014). Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic. Multidisciplinary Respiratory Medicine. 9. 2 indexed citations
17.
Uçar, Elif Yılmazel, Metin Akgün, Ömer Araz, et al.. (2014). Comparison of LMWH Versus UFH for Hemorrhage and Hospital Mortality in the Treatment of Acute Massive Pulmonary Thromboembolism After Thrombolytic Treatment. Lung. 193(1). 121–127. 6 indexed citations
18.
Uçar, Elif Yılmazel, Ömer Araz, Metin Akgün, et al.. (2013). Bronchial anthracosis-anthracofibrosis: Potential causes and clinical features. European Respiratory Journal. 42(Suppl 57). P1016–P1016. 1 indexed citations
19.
Baççıoğlu, Ayşe & Elif Yılmazel Uçar. (2013). Level of knowledge about anaphylaxis among health care providers. Tuberkuloz ve Toraks. 61(2). 140–146. 23 indexed citations
20.
Yıldırım, Abdülkadir, et al.. (2007). Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer.. PubMed. 13(4). CR195–200. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Nihat Annakkaya Breakdown of academic impact, for papers by Rosa M. Estrada‐Y‐Martin Breakdown of academic impact, for papers by Marc C. Smaldone Breakdown of academic impact, for papers by Tatiana Helena Rech Breakdown of academic impact, for papers by Hayriye Sayarlıoğlu Breakdown of academic impact, for papers by Nuri Tutar Breakdown of academic impact, for papers by Şevket Özkaya Breakdown of academic impact, for papers by Nihal Demirel Breakdown of academic impact, for papers by Talal Almas Breakdown of academic impact, for papers by Christian Urbanek
Rankless by CCL
2026